Supplementary protection certificate for medicinal products

This procedure establishes rules for Supplementary Protection Certificates (SPCs), which extend the patent protection for medicinal products. This extension compensates for the long time it takes to obtain regulatory marketing authorization, ensuring that pharmaceutical companies can recover their research and development investments.

This primarily affects pharmaceutical companies and healthcare providers. It balances the incentive for innovation in medicine with the eventual availability of cheaper generic drugs once the extended protection period expires.